Our Stocks to Watch today include Wanderport Corp. (OTC: WDRP), San West Inc. (OTCBB: SNWT), Magnum D'Or Resources Inc. (OTCBB: MDOR), Muscle Flex Inc. (OTC: MFLI), Hitor Group Inc. (OTCBB: HITR), EQ Labs Inc. (OTC: EQLB), Juhl Wind Inc. (OTCBB: JUHL), Plateau Mineral Development Inc. (OTC: PMDP), Discovery Laboratories Inc. (Nasdaq: DSCO), Hard To Treat Diseases Inc. (OTC: HTDS), Mass Hysteria Entertainment Inc. (OTC: MHYS), Guard Dog Inc. (OTC: GRDO) and American Scientific Resources Inc. (OTC: ASFX).
Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.
WANDERPORT CORPORATION (OTC: WDRP)
"Up 412.20% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/WDRP.php
Company Profile: http://www.otcpicks.com/Newsletter/WDRP_eProfile_093009.html
Wanderport Corporation is a holding and business development company specializing in the investment and deployment of environmentally friendly technology such as, primary alternative renewable energy and energy saving products like electric vehicles which reduce global dependence on oil.
WDRP News:
September 30 - Wanderport Signs A Letter Of Intent To Sell Pulsar's Revolutionary Tank-less Water Heaters To
Wanderport Corp. (OTC: WDRP) announced the signing of a letter of intent to sell Pulsar's tank-less microwave energy water heaters to a global sales leader in patented heating systems located in Spain. The agreement will be a multi-million dollar deal exclusive to
"Wanderport remains focused on company growth while developing innovative low consumption, energy efficient products and investments. The world along with the country of
SAN WEST INCORPORATED (OTCBB: SNWT)
Detailed Quote: http://www.otcpicks.com/quotes/SNWT.php
Company Profile: http://www.otcpicks.com/san-west-inc.htm
San West designs, manufacturers, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies; products are sold via three divisions: at retail store locations; via the online store and; through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee California retail location.
SNWT News:
September 29 - San West, Inc. Releases Aggressive Strategic Initiatives Aimed at Increasing Sales Streams and Enhancing Revenue Base
San West, Inc. (OTCBB: SNWT), a Company that designs, manufacturers, sells and repairs off-road buggies, announced today its list of aggressive strategic initiatives aimed at dramatically increasing revenues for the short term fiscal year including the 3rd and 4th Quarter of 2009.
Frank Drechsler, President of San West, Inc., states, "The past year has been a whirlwind of change for this company. Our corporate structure, business model, as well as the marketplace in general, has evolved immensely but we have quickly adapted to changing demand and feel that we are a stronger company for it. Our plans of growth going forward take into consideration the economical changes and challenges we are seeing in the market as well as avenues of growth that make us more diversified and a bigger player in the off-road sports market."
Strategic Initiatives Poised for the Next 12 months:
* Increased focus on Buggy World Internet sector, where many competitors are not reaching target markets for buggy and off-road products. With development of the new website, the company intends to promote itself online through sales, specials and a community forum.
* Pursuit of additional Buggy World dealership locations for increased market coverage and distribution territory as well as distributorships and industry alliances.
* Launch of marketing campaign through advertising, social media and increased industry event presence.
* Increased Buggy World distributorship of large industry brand names and companies such as recent distributorships with Fox Racing and Thor.
* Promotion of Buggy World repair shop and part sales which research shows is an industry niche as well as a revenue stream that increases during times of decreased expendable income.
* Added product inventory, such as Redline and Joyner, which appeals to wider range of sports enthusiasts.
Key Milestones Achieved During Past 12 months:
* Acquisition of Buggy World in October 2008, with reported revenue of $1.6 million for 2007 Merger with Human BioSystems, Inc. making San West a publicly traded company on the OTC Bulletin Board.
* Increased Buggy World part sales/repair shop income by 35% Opening of new Buggy World location in
* New Buggy World representation of top rated product lines such as Fox Racing and Thor Redevelopment of Buggy World website with greater focus on online retail, off-road community and social portal.
* Awarded exclusive TrophyKart dealership for
MAGNUM D'OR RESOURCES (OTCBB: MDOR)
"Up 3.63% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MDOR.php
Company Profile: http://www.otcpicks.com/magnum-resources/magnum-resources.htm
Magnum d'Or Resources, Inc. focuses in operating in recycling and waste management sectors. It intends to develop facilities that produce rubber powders, thermoplastics, and thermoplastics elastomers. Magnum holds licensing rights to various patents that would allow rubber to be devulcanized, specialty blend EPDM powders, and EPDM compounds. The company was founded in 1999 and is based in
MDOR News:
September 30 - Magnum Increases Staff to Accommodate Anticipated Hyper Growth
Magnum D'Or Resources, Inc. (OTCBB: MDOR), a next generation rubber recycling solutions company, announces the recent retention of new staff and consultants to advise the Company, as well as, implement the required tools and programs necessary to allow Magnum to transition smoothly through the upcoming accelerated growth period.
Joseph Glusic, President and CEO of Magnum commented, "The anticipated growth of Magnum over the next several years requires that we implement the necessary infrastructure now so that we can focus on operations, acquisitions, and sales associated with expanding company business. With this in mind we have retained several renowned consultants with exceptional training and experience to help guide us through our upcoming growth phase. We look forward to working with these individuals to help institute state-of-the-art tools necessary to accomplish our goals."
The Company welcomes the retention of the following individuals:
Dr. Hugh Campbell - Engineering and Scientific specialist
Curtis Basner - Operational Procedure specialist
Thomas Hillmer - Environmental and Compliance specialist
Paul Miles - Quality Assurance Expert
Donald Kot - Transportation and Procurement specialist
Donald Brinkmann - Architectural Design and Construction
All of these individuals have impeccable credentials and a wealth of experience in their respective fields of expertise. Space prohibits elaborating on each of their specific specialties and career accomplishments, but bios will be added to the corporate web site in the near future.
MUSCLE FLEX INCORPORATED (OTC: MFLI)
"Up 10.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php
Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm
Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast.
MFLI News:
September 30 - The Muscle Flex/Sterling Worldwide Entertainment's Daytime Primetime TV Show 'Sugar Free' Garners Major Interest From Global Television Distributors
Muscle Flex Inc. (OTC: MFLI) (www.MuscleFlexInc.com) and Sterling Worldwide Entertainment, LLC (www.SterlingWWE.com), a subsidiary of Visual Industries, Inc., jointly announced today that their television show "Sugar Free," which is currently in pre-production, has received significant expressions of interest from global television program distributors and have engaged the interested media conglomerates in discussions regarding the show. Muscle Flex® and
The initial interest is derived from the timely and compelling program content of "Sugar Free" as well as the strong relationships
In an age where more than 21 million people (7% of the population) have diabetes and even more suffer from obesity and other illnesses, "Sugar Free" delivers real-life, practical solutions to anyone seeking to develop and maintain a healthy lifestyle. Hosted by a top-rated TV celebrity with a loyal fan base, "Sugar Free" takes a fun, in-your-face approach to demonstrating sugar-free recipes, exercises, and how to maintain a sugar-free life at work events, lunches, and dinners. In addition, celebrity guest appearances will add variety and depth to keep programming fresh on a daily basis.
"Revenue derived from a television program like Sugar Free can be significant. With the huge success of such TV shows as 'The Biggest Loser' and 'Celebrity Fit Club,' diet and exercise shows have been spun into television gold," said Danny Alex, CEO of Muscle Flex Inc. "'Sugar Free' has it all — the information, ideas and personalized motivation to help viewers get healthy and stay that way. The show is truly different -- it's a cooking lesson, self-help talk show and reality TV all in one."
Kira Baskerville, CEO of Sterling Worldwide Entertainment, said, "'Sugar Free' will be a show that will help many people worldwide live healthier, longer lives.
"Sterling not only possesses the talent and experience to develop an A-class daytime/primetime TV program but they also have long-standing relationships that can propel 'Sugar Free' into widespread distribution globally," commented Danny Alex, CEO of Muscle Flex Inc. "Sterling has successfully launched health and wellness TV shows globally, including the U.K., Europe and the U.S. 'Sugar Free' is one of Muscle Flex's best kept secrets and its potential has not been fully addressed by investors."
The overweight epidemic affects millions of people both young and old. As such, "Sugar Free" is expected to appeal to the 18- to 49-year-old demographic. However, as "self help" and "living a better life" resonates with persons of any age, the show is expected to reach an even broader audience in the U.S. Additional details of the show will be released at a future date in order to protect proprietary content, ideas and information.
ABOUT
Sterling Worldwide Entertainment, LLC, creates and delivers premium products in the entertainment market.
HITOR GROUP INCORPORATED (OTCBB: HITR)
Detailed Quote: http://www.otcpicks.com/quotes/HITR.php
Company Profile: http://www.otcpicks.com/hitr-group-inc.htm
Hitor Group, Inc., a development stage company, owns a proprietary technology related to a fuel saving device. Its product would allow owners and operators of gasoline and diesel powered vehicles to increase fuel efficiency while reducing fuel emissions into the environment. The company also focuses on oil extraction, transport, and storage solutions, as well as on alternative powered private and commercial vehicles. Its target customers include the American and international trucking and automobile parts distribution companies, oil companies, and alternative fuel vehicle distributors. The company, formerly known as Nano-Jet Corporation, is based in
HITR News:
September 30 - Nano-Jet Releases Fuel Performance Enhancement Module Test Results
Nano-Jet Corporation, a wholly owned subsidiary of Hitor Group, Inc. (OTCBB: HITR), announces the results of several field tests of models of its Nano-Jet Fuel Module. Nano-Jet Corporation is the sole owner and producer of the worldwide patent applied for Nano-Jet line of fuel performance enhancing devices, the most highly refined and effective technology of its kind available in the market today.
These field tests of the Nano Fuel Module were voluntarily performed by potential future Nano-Jet customers on an informal basis with a focus on fuel savings and emission reduction. A synopsis of the test results as follows:
* H & H Trucking reported a 20% fuel savings (diesel).
* KDK reported a 17% fuel savings on a Ford F-250 (diesel).
* A.T.M. Trucking reported a 14% fuel savings (diesel).
* Klose Trucking reported a 19.9% fuel savings (diesel).
* EJ&E Railway reported 3% fuel savings on a locomotive (diesel).
* Central Transport reported 17% Emission reduction, (diesel) 14% fuel savings, 11% compression increase. Average over three separate tests.
* Raadstat Racing: "We tested the Nano-Jet on a 250cc Yamaha Motocross motorbike, the bike has shown spectacular results with engine performance, in the lower gears torque equaled a 400cc bike. Starting gate, jumps and turns showed a quicker recovery. In third gear we were able to pop a low wheelie. In a 5 lap heat we were able to reduce time by 28 seconds (this should increase as the riders become more familiar with the Nano-Jet)." - Don Raadstat, Racing Manager.
These impressive results will soon be reinforced by data from additional field testing and upcoming independent testing to be performed by the following prestigious institutions:
* The
* Two North American Universities independent studies.
* CAVCO, Inc., Clean Air Vehicle Company,
"These test results provide an exciting initial view of the impressive fuel savings that are obtainable by the installation of the Nano-Jet Device on trucking fleets," stated Ken Martin, CEO of Nano-Jet Corporation. "This just the tip of the iceberg and we will imminently be releasing news about more Nano-Jet developments, as we continue our preparations to make a strong entrance into the target markets."
ABOUT NANO-JET
Nano-Jet Corporation, a wholly owned subsidiary of Hitor Group, Inc. (OTCBB: HITR), is the sole owner and producer of the patented Nano-Jet line of magnetic fuel performance enhancing Modules. Nano-Jet offers the most highly refined and effective fuel performance enhancement technology available in the market today. Nano-Jet's proprietary design magnetically restructures and polarizes fuel molecules to enable a more complete combustion of the fuel/air mix. Extensive testing of the line of Nano-Jet models on a variety of gasoline and diesel engines has conclusively proven that fuel treated by these fuel performance optimizing devices produces measurably more power, increases fuel economy by an average of 7-12% and reduces toxic exhaust emissions up to 30%.
The Nano-Jet Fuel Module is suitable for use with a wide variety of internal combustion power plants from the smallest single cylinder gasoline engine to diesel railroad locomotives and marine diesels large enough to power ocean going ships.
EQ LABS INCORPORATED (OTC: EQLB)
Detailed Quote: www.otcpicks.com/quotes/EQLB.php
Company Profile: http://www.otcpicks.com/eq-labs.htm
Headquartered in Las Vegas, NV, EQ Labs, Inc. manufactures and markets the EQ Smart Energy Drink®, which is an effervescent tablet that provides an instant energy drink once added to any beverage. Consisting of a blend of essential vitamins, a single tablet of EQ Smart Energy Drink® (containing no sugar and only 5 calories per serving) is the equivalent of one can of any competing energy drink on the market. EQ is sold in packets of one single tablet or 3-inch tubes of six tablets, and no refrigeration is required. A single tablet or 3-inch tube containing six tablets can be transported in a pocket or purse, and is immediately ready for use. The company presently distributes its products through national and regional distributors.
EQLB News:
September 28 - EQ Labs Smart Energy Drink Complements the Energy Drink Industry
When deciding to make
Given the abundance of energy drink manufacturers in the
"This strategy, while simplistic, is paying off tremendously," stated Mike Villa, the Company's Sales Manager. "Yes, we've been fortunate enough to enter into agreements with large, national distributors like McLane Distributors Co., who service thousands of 7-Eleven (corporate-owned convenience stores), but our goal to place our product in the hundreds of 7-Eleven franchise stores in the Las Vegas area has also been realized. It entailed calling on local merchants and demonstrating the added value of stocking our products — selling them on the fact that EQ Smart Energy Drink tablets will complement and increase their energy drink sales."
"In essence, they could receive a substantial mark-up margin by offering an energy drink product for less than $1.00 per unit," he added. "As a result of securing sales agreements with local distributors like FoodPro and increasing the number of accounts with retail outlets throughout the region, we were able to hire and train additional sales staff to systematically introduce the product throughout the region," Villa went on to state.
"This is good news," stated Bob Fain, the COO of EQ Labs, Inc. "It demonstrates the commercial success of our product on a local basis, which has opened doors to other domestic markets. When we embarked on this strategy, our belief was that it didn't make sense to overlook the multitude of smaller distribution opportunities right here in our backyard, while chasing after larger companies outside of our own geographic region. We believe our successes complemented the energy drink industry by providing viable alternatives for local consumers. Given the millions of visitors to
JUHL WIND INCORPORATED (OTCBB: JUHL)
Detailed Quote: http://www.otcpicks.com/quotes/JUHL.php
Company Profile: http://www.otcpicks.com/juhl-wind-inc/juhl-wind-inc.htm
Juhl Wind is an established leader in Community Based Wind Power development and management, focused on wind farm projects throughout the
JUHL News:
September 29 - SmallCapSentinel.com: Report On Wind Energy Industry Released
A Murphy Analytics report and profile featuring Juhl Wind, Inc. (OTCBB: JUHL) and detailing the latest events in wind energy has been released. This report is of potential interest to investors of the following wind power companies: Xcel Energy Inc. (NYSE: XEL), Trinity Industries Inc. (NYSE: TRN), Otter Tail Corporation (Nasdaq: OTTR) and Kaydon Corporation (NYSE: KDN).
The report and profile also examine JUHL historical results and illustrates the JUHL revenue model at:
http://www.murphyanalytics.com/uploads/JUHL_Initiation
From the report: While grid and transmission problems slow or render impossible the development of many utility scale wind power projects, the community wind distributed generation model creates an enormous opportunity for areas where the large projects will not be a fit any time soon. JUHL estimates that meeting the Department of Energy's call for 20% wind power by 2030 will require $15 billion in annual development investment to grow domestic wind power generation to an estimated requirement of 304 gigawatts. As noted in the American Wind Energy Association's 2nd Quarter Market Report1, large scale, utility sized projects will continue to be a significant driver of overall development. However, led by industry pioneer Dan Juhl and a proven management team, JUHL is positioned to thrive as a result of the abundance of small wind opportunities made possible by the distributed generation approach. JUHL's NextGen consumer owned renewable energy products segment serves as a strong strategic and economic complement to the Company's legacy experience.
PLATEAU MINERAL DEVELOPMENT INCORPORATED (OTC: PMDP)
"Up 20.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PMDP.php
Plateau Mineral Development, Inc. specializes in the exploration and development of energy sources. Its partner, Plateau Mineral Development LLC, has been in existence for over five years with successful new wells and rework wells selling both gas and oil.
PMDP News:
July 15 - Plateau Mineral Development, Inc. Announces Solar Collector
Plateau Mineral Development, Inc. (OTC: PMDP), along with its partner, Plateau Mineral Development LLC, announced today that the firm, in conjunction with MEI, is moving to secure several features of its improved solar collector.
The unit, produced and installed in the early 1980s, is being upgraded with the inclusion of photo-voltaic capability. The unit acts as a concentrator under clear skies and as a flat plate when sunlight is diffused by dust or clouds.
A representative of Plateau Mineral Development states, "Additionally, a research and development plan and budget have been prepared to research means of enhancing the photo-voltaic output. Understandably, aspects of this research and development are being held in strictest confidence. We will update our shareholders on portions of the research that are deemed appropriate for dissemination as soon as the details are available to us."
DISCOVERY LABS INCORPORATED (NASDAQ: DSCO)
"Up 45.05% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DSCO.php
Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs' novel proprietary KL4 Surfactant Technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations. In addition, Discovery Labs' proprietary Capillary Aerosolization Technology produces a dense aerosol, with a defined particle size that is capable of potentially delivering aerosolized KL4 surfactant to the deep lung without the complications currently associated with liquid surfactant administration. Discovery Labs is focused initially on developing its KL4 surfactant pipeline to build a pediatric franchise that will potentially address several respiratory conditions affecting neonates and young children, beginning with Respiratory Distress Syndrome (RDS).
DSCO News:
September 30 - Discovery Labs and FDA Establish Path for Potential Surfaxin Approval
FDA Supports Proposed BAT Optimization and Approach for Limited Clinical Trial
Discovery Laboratories, Inc. (Nasdaq: DSCO) held a teleconference on September 29, 2009 with the U.S. Food and Drug Administration (FDA). The meeting established an approach to potentially resolve the remaining primary issue that Discovery Labs must address to gain
At the meeting, the FDA indicated that Discovery Labs' proposed program to optimize and validate the BAT is reasonable. The program is intended, among other things, to confirm that the BAT can adequately distinguish change in Surfaxin biological activity over time. As a result of the meeting, Discovery Labs believes that it has reached an understanding with the FDA and is confident that it will be able to optimize the BAT to the satisfaction of the FDA. Discovery Labs intends to employ the optimized BAT in conjunction with all of Discovery Labs' KL4 surfactant pipeline programs, including the potential limited Surfaxin clinical trial.
In addition, Discovery Labs received guidance from the FDA on its proposed limited clinical trial design. The trial design is intended to primarily assess a pharmacodynamic (PD) response following Surfaxin administration in preterm infants with RDS. This design was selected to address FDA requirements for Surfaxin approval while limiting trial expense and duration. The FDA indicated that a PD-based approach is consistent with their expectation for a limited clinical trial and also provided direction regarding trial design specifics. The final clinical trial design will be subject to FDA review following submission of a formal protocol. Discovery Labs expects to finalize a protocol and anticipates submitting it to the FDA in mid-fourth quarter of 2009.
W. Thomas Amick, Chairman of the Board and Chief Executive Officer of Discovery Labs, commented, "We are pleased with the guidance received and outcomes obtained from our interaction with the FDA. This guidance provides a viable option for Surfaxin and meaningfully supports advancing our pipeline initiatives to potentially address a broad range of respiratory diseases such as RDS, Acute Respiratory Failure, Acute Lung Injury and Cystic Fibrosis. We look forward to continued productive dialogue with the FDA.
"Our most advanced programs from our KL4 surfactant pipeline, Surfaxin, Surfaxin LS(TM) and Aerosurf(R), have the potential to greatly improve the management of RDS and to redefine the RDS market. Our top priority is to secure strategic alliance partners and access capital to advance our pipeline and build shareholder value. As we move forward, we will take into account further interaction with the FDA and make strategic assessment, together with existing and potential new partners to determine the appropriate level and timing of Surfaxin investment and to maximize the value of our KL4 pipeline for RDS."
Background
On April 17, 2009, Discovery Labs received a Complete Response letter from the FDA for Surfaxin for RDS and on June 2, 2009, conducted a related meeting focusing primarily on certain aspects of the BAT, specifically whether preclinical data generated using both the BAT and a well-established preterm lamb model of RDS adequately supports the comparability of Surfaxin clinical drug product to the to-be-manufactured Surfaxin, and whether the BAT can adequately distinguish change in Surfaxin biological activity over time.
During the conduct of Phase 3 clinical trials for Surfaxin, Discovery Labs employed an array of quality control tests, but did not employ the BAT to evaluate biological activity of the Surfaxin clinical drug product. After completing the Phase 3 clinical trials, in accordance with discussions with the FDA, Discovery Labs validated and implemented the BAT as a recurring quality control test to confirm biological activity for Surfaxin release and stability testing. Based on guidance received from the FDA in meetings with the FDA in 2006 and 2008, Discovery Labs conducted a series of preclinical experiments to establish comparability between Surfaxin drug product used in Phase 3 clinical trials and the Surfaxin drug product intended to be manufactured for commercial use. Accordingly, Discovery Labs initiated a series of side-by-side studies employing both the preterm lamb model of RDS and the BAT and believes that the correlated results demonstrate comparability and support approval of Surfaxin.
At the June 2 meeting with the FDA, Discovery Labs presented data from the preterm lamb model and BAT studies, together with a comprehensive statistical evaluation of such data, intended to establish the comparability of clinical drug product to Surfaxin drug product to be manufactured for commercial use. The comprehensive statistical evaluation was a comparative regression analysis using an accepted FDA statistical method. Discovery Labs believes that the data and related statistical evaluation are highly supportive of the comparability of clinical drug product to commercial Surfaxin.
However, the FDA stated at the June 2 meeting that data generated from the preterm lamb model and BAT studies must demonstrate, in a point-to-point analysis, the same relative changes in respiratory compliance between both models over time. Based on this standard, Discovery Labs believes that establishment of comparability in this manner would be an extremely high hurdle and that, from the FDA's perspective, the data analysis provided by Discovery Labs did not meet that standard.
In addition, the FDA suggested that the comparability studies in the preterm lamb model and the BAT would not be necessary if the BAT had been implemented to assess Surfaxin drug product used in the Phase 3 clinical trials. The FDA also suggested that, to increase the likelihood of gaining Surfaxin approval and as an alternative to demonstrating comparability using the preterm lamb model and BAT, Discovery Labs could consider conducting a limited clinical trial, while simultaneously employing the BAT, as a path forward to Surfaxin approval.
HARD TO TREAT DISEASES INCORPORATED (OTC: HTDS)
"Up 8.33% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/HTDS.php
In June 2003, International Foam Solutions, Inc. changed its name to Hard to Treat Diseases, Inc. in connection with the completion of a share exchange agreement with Hard to Treat Diseases and T-19, Inc. Hard to Treat Diseases, Inc. holds the international marketing rights, except South Korea, to Tubercin, a patented immunostimulant developed for combating cancer and rheumatoid arthritis under medical patent. Tubercin promotes good health by enhancing the immune system. The nasal spray would be distributed through major holistic retailers and providers worldwide.
HTDS News:
September 29 - Hard to Treat Diseases Obtains H1N1 License with
Hard To Treat Diseases (OTC: HTDS) China-based operating subsidiary Mellow Hope, through its exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd has been granted H1N1 license on September 24, 2009 by SFDA (China Authority). Mellow Hope is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd for International marketing and sales
The issuer completed a set of filings in both Chinese and English translations on Pink Sheets. Also, the company promised in two separate news releases of September 2009 that it will release the name of its exclusive partnership. The filings and supporting H1N1 documents on Pink Sheets are self explanatory.
The company believes that there is a naked short interest in the stock and the company has retained counsel to investigate this matter and possible market manipulation by short sellers. In this connection, the Company has received numerous allegations and complaints from shareholders. In addition, the company has been the victim of anonymous "stock bashing" and a campaign of negative publicity, a smear campaign. In fact, there is a lawsuit in progress on some of these issues.
"We believe that the full potential of our H1N1 vaccine business has yet to be realized in our stock price and this report outlines some of the issues involved," said HTDS CEO Terry Yuan. "Take a good look at all that is going on now for HTDS and you may be surprised to find that when you do so, you share our enthusiasm for HTDS. H1N1 is done and completed so we are eager to start to profit from this huge demand from customers who want to now buy HTDS products immediately. We are also moving with great energy to get our audits completed and get OTCBB listed. When you look at the potential cancer and anti-aging projects of Slavica Bio Chem it is easy to find yourself strongly visualizing their enormous potential. HTDS is also taking aggressive action against the suspected naked shorting that has apparently affected our stock so we can remove all possible barriers to appreciation and give our investors confidence in the future of their investment. Further, most people do not seem to realize we have recently made a sizable recent reduction in our stock outstanding and understand fully what that means. When you add all the excitement all this has created to our eagerness to move forward, it can cause you to start to see that we are on verge of a major expansion. We believe you have to find yourself putting HTDS in that spot in your mind where you would put a company that has virtually unlimited upside. We look forward to the future and we believe that a year from now we will find ourselves looking back on back on this time as one where we all participated in a major expansion."
MASS HYSTERIA ENTERTAINMENT COMPANY INCORPORATED (OTC: MHYS)
"Up 20.93% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MHYS.php
Mass Hysteria Entertainment, Inc. is led by one of the driving forces behind the Independent Film business. Mr. Grodnik, CEO, has a career that spans roughly three decades. He has worked with every major studio as well as many of the better-known Independent companies. Currently, Mr. Grodnik is preparing a thriller titled "Carjacked," starring Ron Pearlman and directed by Peter Mednak; and the "Courier," an action film to be directed by Russell Mulcahy. Mr. Grodnik completed a romantic comedy last March titled, "Overnight" and is in development of a new theatrical film with two-time Academy Award winner for best picture, ("The Godfather" and "Million Dollar Baby") Albert S. Ruddy.
MHYS News:
September 30 - Mass Hysteria Announces New Office Location in the Heart of
Mass Hysteria Entertainment (OTC: MHYS) CEO Daniel Grodnik announced that the company has relocated to the heart of
Mass Hysteria Entertainment is a new multi-media entertainment company created to produce film comedies for the young adult market with a proprietary interactive component. Mass Hysteria is the next step in the evolution of film: a hybrid entertainment that combines movies with hand-held devices, the internet, and live theater. It was recently reported that Pat Proft, the writer of such seminal film comedies as Warner Bros.' Police Academy Series and
GUARD DOG INCORPORATED (OTC: GRDO)
"Up 13.33% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/GRDO.php
Guard Dog, Inc. is rapidly accelerating to become an industry leader in the rapidly growing field of Identity Theft Protection. The company strives to serve the growing needs of consumers throughout the
GRDO News:
July 13 - Guard Dog Launches Corporate Affinity Program: Identity Theft Protection Services Employee Benefits Program
Guard Dog Inc. (OTC: GRDO) announced that Guard Dog ID, LLC, an industry leader in identity theft prevention services, has launched a new corporate marketing program. Guard Dog will partner with corporate affiliates by targeting large corporations that wish to offer identity theft protection services as both a part of their employee benefits package and as an additional value added benefit that can be made available to customers and clients.
The Guard Dog corporate program will be free to join and will offer tiered group membership discounts to corporate partners while benefitting subscribers directly. Guard Dog will supply all of the tracking and advertising tools affinity marketers will need to launch their campaign and maximize participation through the newly enhanced Guard Dog web portal. Program participation will require no technical knowledge during account sign-up or set-up. Guard Dog plans to utilize a broad range of banners suitable for both website and email newsletter publication.
“We have entered into discussions with a national real estate company to offer our identity theft services to approximately 72,000 agents and their clients as part of our new preventative services program. Our company spokesperson, Kendra Todd, will be prominently featured in the campaign and will present the value added benefits of the program in both live and all print media,” stated James Watson President and CEO of Guard Dog ID, Inc.
“As a respected leader in the Real Estate Industry, it is fitting that our company spokesperson, Kendra Todd, present the value added benefits of our identity protection services during this campaign. The campaigns’ focus will be on changing attitudes from reactive to proactive. When everything is said and done, there is no disputing the fact that the nominal costs of prevention far outweigh the costs of inaction which can result in victimization down the road,” continued Watson.
AMERICAN SCIENTIFIC RESOURCES INCORPORATED (OTC: ASFX)
"Up 30.68% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ASFX.php
American Scientific Resources, Inc. is a holding company for two wholly owned subsidiaries, Kidz-Med, Inc. and Heart Smart System. The Company's objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market.
ASFX News:
September 29 - Better TV Meets a Better Thermometer for Cold and Flu Season
Safety Mom talks cold and flu prevention tips featuring must-have Kidz-Med products
Kidz-Med Inc., a subsidiary of American Scientific Resources, Inc. (OTC: ASFX) announced that the Kidz-Med Thermofocus 5-in-1 Non-Contact Thermometer and Pacifier Medicine Dispenser will be featured on Better TV airing live from 10-11am EST on CBS - TV channel 3 Connecticut Tuesday, September 29.
Alison Rhodes (The Safety Mom) has picked her must have products for the cold and flu season, and will be featuring them in a show and tell segment on Better TV in Connecticut on tips for preventing and caring for children who are sick during the cold and flu season.
Ms. Rhodes has previously highlighted the Thermofocus 5-in-1 thermometer on a home media tour as one of the great safety inventions of 2009, and she has been featured on numerous television segments discussing child safety, heath and wellness including ABC's Good Morning America, NBC's The Today Show, ABC World News Tonight, Court TV, Oxygen's The Gayle King Show, PBS' Keeping Kids Healthy, Discovery Health's Runway Moms, NBC's Open House, CNN and CNBC.
Not Better, but the Best Thermometer
One of the web's most well-known magazine sites for the modern day parent, Babble.com, found Kidz-Med's Thermofocus 5-in-1 to be one of the best painless temperature readers, and the only device where "you can get a 1-second contact-free temperature reading."
A Lil' Sugar Helps the Medicine Go Down
A list of 10 ways to help the medicine go down was published on the ever-popular mom destination, LilSugar.com, and the Kidz-Med pacifier medicine dispenser was at the top as a helpful way to administer medicine to children.
The Kidz-Med Thermofocus 5-in-1 non-contact thermometer can be seen on Fox & Friends, NBC-TV channel 9, Denver, KTLA - TV Los Angeles, KSWB-TV Fox 5, San Diego, WTSP-TV CBS-News 10, Tampa Bay, and YouTube.com. It has also been profiled in the South Florida Business Journal, the Pittsburgh Tribune-Review and the Tulsa World as well as at People's Celebrity-Babies.com, MomGenerations.com, Thingamababy.com, MommiesWithStyle.com, Cafemom.com, MommaFindings.com, ResourcefulMommy.com and Buzzillions.com.
ABOUT KIDZ-MED, INC.
A division of American Scientific Resources, Inc., Kidz-Med, Inc., was founded in 1993 by Dr. Christopher F. Tirotta to create children's pre-operative educational videos "A Hospital Trip With Dr. Bip" and "Dr. Bip's New Baby Tips". Today, Kidz-Med, Inc. is leading the pediatric and children's health and safety products industry in innovation by providing the most revolutionary patented family-friendly products sourced from around the globe to help keep children safe and parents reassured.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org.
Disclosure: OTCPicks.com has been compensated three thousand five hundred dollars by a third party (Green Horseshoe) for SNWT advertising and promotional services. OTCPicks has been compensated ten thousand dollars from a non-controlling third party (GREEN TECH INTERNATIONAL ADVISORS) for MDOR advertising and promotional services. OTCPicks.com is currently being compensated eight thousand dollars from Danny Alex for MFLI advertising and promotional services and was compensated three thousand five hundred dollars from Dana Alex for a prior MFLI advertising and promotional campaign. OTCPicks.com has been compensated eight thousand dollars by a third party for WDRP advertising and promotional services. OTCPicks has been compensated three thousand five hundred dollars from a non-controlling third Party (Level Up Industries) for HITR advertising and promotional services. OTCPicks.com has been compensated twenty five thousand shares by BlueWave Advisors for EQLB advertising and promotional services. OTCPicks.com has been compensated an additional three thousand five hundred dollars by a third party (Level Up Industries) for EQLB advertising and promotional services. OTCPicks has been compensated four thousand five hundred dollars from a non-controlling third Party (BlueWave Advisors) for JUHL advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
